Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Savara Inc
(NQ:
SVRA
)
3.410
+0.050 (+1.49%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Savara Inc
< Previous
1
2
3
4
5
Next >
Savara Reports Second Quarter Financial Results and Provides Business Update
August 10, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
August 04, 2023
From
Savara Inc.
Via
Business Wire
Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday
July 20, 2023
U.S. stocks traded mixed, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares rose...
Via
Benzinga
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
July 13, 2023
From
Savara Inc.
Via
Business Wire
Why Shares of Savara Soared This Week
January 27, 2023
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.
Via
The Motley Fool
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
June 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Savara Added to Russell 3000® Index
June 26, 2023
From
Savara Inc.
Via
Business Wire
Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
June 26, 2023
From
Savara Inc.
Via
Business Wire
Savara to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Savara Inc.
Via
Business Wire
Barnwell Industries And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
May 30, 2023
The Dow Jones closed higher by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Why Shares of Savara Jumped on Tuesday
May 16, 2023
The company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy.
Via
The Motley Fool
Savara Reports First Quarter Financial Results and Provides Business Update
May 15, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
May 05, 2023
From
Savara Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
April 03, 2023
Via
Benzinga
Savara Announces New Employment Inducement Grant
March 31, 2023
From
Savara Inc.
Via
Business Wire
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update
March 30, 2023
From
Savara Inc.
Via
Business Wire
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2023
From
Savara Inc.
Via
Business Wire
JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 21, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Savara Announces New Leadership Appointments
February 14, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
January 20, 2023
From
Savara Inc.
Via
Business Wire
$1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
January 04, 2023
The Dow Jones edged lower on the first trading session of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Savara Announces New Employment Inducement Grant
November 22, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Savara Inc.
Via
Business Wire
Savara to Participate in Three Upcoming Investor Conferences
November 09, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
September 14, 2022
From
Savara Inc.
Via
Business Wire
Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
September 06, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 01, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Resignation of Chief Medical Officer
August 26, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
August 25, 2022
From
Savara Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.